The high selectivity for Omicron S protein over other protein-based biomarkers for infectious diseases and even over other S proteins from other SARS-CoV-2 variants enables a variant selective detection of infections with Omicron SARS-CoV-2 viruses. This evidence concerns the gene PROS1 and infectious disease.